One thing is that, in trials, some of these new medications are increasing the amount of weight loss, but that means higher reward, higher risk, with more side effects, says John Morton, MD, MPH, chief of Yale Medicine Bariatric and Minimally Invasive Surgery and a board-certified obesity medicine specialist
In July alone she says she made $5,000
AGA clinical practice guideline on pharmacological interventions for adults with obesity
Retatrutide is currently an investigational triple-agonist medication being studied for obesity and metabolic health
By chewing food thoroughly and taking more time during meals, we allow the stomach to register the quantity and taste of the food, helping us feel full faster and eat the appropriate amount
Weekly trends reveal the true trajectory